Androgen deprivation and immunotherapy for the treatment of prostate cancer von Gamat, Melissa, McNeel, Douglas G

Volltext

Role of B cells as antigen presenting cells von Rastogi, Ichwaku, Jeon, Donghwan, Moseman, Jena E, Muralidhar, Anusha, Potluri, Hemanth K, McNeel, Douglas G

Volltext

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma von Choueiri, Toni K, Fishman, Mayer N, Escudier, Bernard, McDermott, David F, Drake, Charles G, Kluger, Harriet, Stadler, Walter M, Perez-Gracia, Jose Luis, McNeel, Douglas G, Curti, Brendan, Harrison, Michael R, Plimack, Elizabeth R, Appleman, Leonard, Fong, Lawrence, Albiges, Laurence, Cohen, Lewis, Young, Tina C, Chasalow, Scott D, Ross-Macdonald, Petra, Srivastava, Shivani, Jure-Kunkel, Maria, Kurland, John F, Simon, Jason S, Sznol, Mario

Volltext

Toll-like receptor agonists as cancer vaccine adjuvants von Jeon, Donghwan, Hill, Ethan, McNeel, Douglas G.

Volltext

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA von Rastogi, Ichwaku, McNeel, Douglas G.

Volltext

Molecular Imaging of Immunotherapy Targets in Cancer von Ehlerding, Emily B, England, Christopher G, McNeel, Douglas G, Cai, Weibo

Volltext

Immunotherapy for prostate cancer: False promises or true hope? von Rekoske, Brian T., McNeel, Douglas G.

Volltext

Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression von Jeon, Donghwan, McNeel, Douglas G.

Volltext

PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy von Zahm, Christopher D., Moseman, Jena E, Delmastro, Lauren E., G. Mcneel, Douglas

Volltext

Targeted Radiation and Immune Therapies-Advances and Opportunities for the Treatment of Prostate Cancer von Muralidhar, Anusha, Potluri, Hemanth K, Jaiswal, Tanya, McNeel, Douglas G

Volltext

Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer von Tonelli, Tommaso P., Eickhoff, Jens C., Johnson, Laura E., Liu, Glenn, McNeel, Douglas G.

Volltext

Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy von Muralidhar, Anusha, Gamat-Huber, Melissa, Vakkalanka, Sita, McNeel, Douglas G

Volltext

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer von MCNEEL, Douglas G, DUNPHY, Edward J, LIU, Glenn, EICKHOFF, Jens C, WILDING, George, DAVIES, James G, FRYE, Thomas P, JOHNSON, Laura E, STAAB, Mary Jane, HORVATH, Dorothea L, STRAUS, Jane, ALBERTI, Dona, MARNOCHA, Rebecca

Volltext

Vaccines as treatments for prostate cancer von Rastogi, Ichwaku, Muralidhar, Anusha, McNeel, Douglas G.

Volltext

Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses von Morse, Matthew D, McNeel, Douglas G

Volltext

TCR diversity – a universal cancer immunotherapy biomarker? von McNeel, Douglas G.

Volltext

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC) von McNeel, Douglas G, Eickhoff, Jens C, Wargowski, Ellen, Johnson, Laura E, Kyriakopoulos, Christos E, Emamekhoo, Hamid, Lang, Joshua M, Brennan, Mary Jane, Liu, Glenn

Volltext

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy von Smith, Heath A., McNeel, Douglas G.

Volltext

Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer von McNeel, Douglas G, Emamekhoo, Hamid, Eickhoff, Jens C, Kyriakopoulos, Christos E, Wargowski, Ellen, Tonelli, Tommaso P, Johnson, Laura E, Liu, Glenn

Volltext

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles von Sullivan, Jeremy A, AlAdra, David P, Olson, Brian M, McNeel, Douglas G, Burlingham, William J

Volltext